跳至主要内容
临床试验/CTRI/2024/07/069861
CTRI/2024/07/069861尚未招募4 期

To evaluate the efficacy and safety of zinc as an add on therapy to prednisolone for producing early remission of pediatric nephrotic syndrome: A randomized controlled trial - Nil

Bhagat Phool Singh Govt.Medical College For Women0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • 1. Hospitalized children of age group 1-15 years presenting with 1st episode of nephrotic syndrome (as per criteria given in annexure 1)
  • 2. Children whose parents/guardians are willing to give written informed consent to participate in the study.

排除标准

  • 1. Children whose parents/guardians are not willing to give written informed consent to participate in the study.
  • 2. Children with malabsorption
  • 3. Children with malnutrition
  • 4. Children with hepatic problems
  • 5. History of chronic illness
  • 6. Secondary causes of nephrotic syndrome.

研究者

发起方
Bhagat Phool Singh Govt.Medical College For Women

相似试验